Jacobs Levy Equity Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-62,645
| Closed | -$1.13M | – | 1125 |
|
|
2020
Q3 | $1.13M | Sell |
62,645
-10,927
| -15% | -$197K | 0.01% | 639 |
|
|
2020
Q2 | $1.87M | Buy |
+73,572
| New | +$1.87M | 0.02% | 547 |
|
|
2020
Q1 | – | Sell |
-17,829
| Closed | -$393K | – | 1133 |
|
|
2019
Q4 | $393K | Sell |
17,829
-14,100
| -44% | -$311K | ﹤0.01% | 817 |
|
|
2019
Q3 | $459K | Buy |
+31,929
| New | +$459K | 0.01% | 728 |
|
|
2017
Q1 | – | Sell |
-55,319
| Closed | -$159K | – | 1043 |
|
|
2016
Q4 | $159K | Sell |
55,319
-400
| -0.7% | -$1.15K | ﹤0.01% | 854 |
|
|
2016
Q3 | $328K | Sell |
55,719
-38,700
| -41% | -$228K | 0.01% | 790 |
|
|
2016
Q2 | $283K | Buy |
94,419
+30,473
| +48% | +$91.3K | 0.01% | 896 |
|
|
2016
Q1 | $343K | Buy |
+63,946
| New | +$343K | 0.01% | 827 |
|